Purdue Pharma

Latest stories

14h
Deseret News
Panel: Painkiller training should be required for physiciansdoes. The educational programs are funded by 23 companies that market the long
Panel: Painkiller training should be required for physicians
Deseret News / Posted 14 hours ago
does. The educational programs are funded by 23 companies that market the long-acting opioids, including OxyContin-maker Purdue Pharma, Endo Pharmaceuticals, Pfizer Inc. and Johnson & Johnson. The content of the training is based on FDA... Read more
37 related stories
15h
Island Packet
Panel: Painkiller training should be required for physiciansdoes. The educational programs are funded by 23 companies that market the long
Panel: Painkiller training should be required for physicians
Island Packet / Posted 15 hours ago
does. The educational programs are funded by 23 companies that market the long-acting opioids, including OxyContin-maker Purdue Pharma, Endo Pharmaceuticals, Pfizer Inc. and Johnson & Johnson. The content of the training is based on FDA... Read more
37 related stories
16h
WDIO Duluth
Panel: Painkiller Training Should Be Required for Physiciansdoes. The educational programs are funded by 23 companies that market the long
Panel: Painkiller Training Should Be Required for Physicians
WDIO Duluth / Posted 16 hours ago
does. The educational programs are funded by 23 companies that market the long-acting opioids, including OxyContin-maker Purdue Pharma, Endo Pharmaceuticals, Pfizer Inc. and Johnson & Johnson. The content of the training is based on FDA... Read more
37 related stories
18h
Your Hometown Lima Stations
Panel: Painkiller training should be required for physiciansdoes. The educational programs are funded by 23 companies that market the long
Panel: Painkiller training should be required for physicians
Your Hometown Lima Stations / Posted 18 hours ago
does. The educational programs are funded by 23 companies that market the long-acting opioids, including OxyContin-maker Purdue Pharma, Endo Pharmaceuticals, Pfizer Inc. and Johnson & Johnson. The content of the training is based on FDA... Read more
37 related stories
20h
ABC News
FDA Advisers Reconsider Training for Painkiller Prescribersdoes. The educational programs are funded by 23 companies that market the long
FDA Advisers Reconsider Training for Painkiller Prescribers
ABC News / Posted 20 hours ago
does. The educational programs are funded by 23 companies that market the long-acting opioids, including OxyContin-maker Purdue Pharma, Endo Pharmaceuticals, Pfizer Inc. and Johnson & Johnson. The content of the training is based on FDA... Read more
37 related stories
1d
The Hill
How Perdue Pharma and the nation's sheriffs are saving livesThe nation is in the grips of a harrowing opiate epidemic that threatens to des
How Perdue Pharma and the nation's sheriffs are saving lives
The Hill / Posted yesterday
The nation is in the grips of a harrowing opiate epidemic that threatens to destroy us from the inside. ADVERTISEMENT Purdue Pharma has provided the National Sheriffs’ Association with a $350,000 grant to train sheriffs how to use the “rescue... Read more
5d
The Globe and Mail
Ottawa urged to reconsider tamper-resistant oxycodoneas we have seen so tragically with fentanyl in our communities,” Health Ministe
Ottawa urged to reconsider tamper-resistant oxycodone
The Globe and Mail / Posted 5 days ago
as we have seen so tragically with fentanyl in our communities,” Health Minister Jane Philpott said in a statement Friday. Purdue Pharma, a leading opioid manufacturer, holds the patent on tamper-resistant oxycodone with its OxyNEO drug, an updated... Read more
7d
Connecticut Post
Prince and the Opioid Epidemic: ‘These Are Essentially Heroin Pills,’ Expert SaysUnited States were “pretty rare.” That changed, however, due to a “brilliant ma
Prince and the Opioid Epidemic: ‘These Are Essentially Heroin Pills,’ Expert Says
Connecticut Post / Posted 7 days ago
United States were “pretty rare.” That changed, however, due to a “brilliant marketing campaign” by pharmaceutical company Purdue Pharma as it introduced its product Oxycontin to the market in 1996. “It was a multi-faceted campaign that led the... Read more
3 related stories
7d
Darien News-Review
Prince and the Opioid Epidemic: ‘These Are Essentially Heroin Pills,’ Expert SaysUnited States were “pretty rare.” That changed, however, due to a “brilliant ma
Prince and the Opioid Epidemic: ‘These Are Essentially Heroin Pills,’ Expert Says
Darien News-Review / Posted 7 days ago
United States were “pretty rare.” That changed, however, due to a “brilliant marketing campaign” by pharmaceutical company Purdue Pharma as it introduced its product Oxycontin to the market in 1996. “It was a multi-faceted campaign that led the... Read more
3 related stories
7d
San Antonio Express-News
Prince and the Opioid Epidemic: ‘These Are Essentially Heroin Pills,’ Expert SaysUnited States were “pretty rare.” That changed, however, due to a “brilliant ma
Prince and the Opioid Epidemic: ‘These Are Essentially Heroin Pills,’ Expert Says
San Antonio Express-News / Posted 7 days ago
United States were “pretty rare.” That changed, however, due to a “brilliant marketing campaign” by pharmaceutical company Purdue Pharma as it introduced its product Oxycontin to the market in 1996. “It was a multi-faceted campaign that led the... Read more
3 related stories
7d
Stamford Advocate
Prince and the Opioid Epidemic: ‘These Are Essentially Heroin Pills,’ Expert SaysUnited States were “pretty rare.” That changed, however, due to a “brilliant ma
Prince and the Opioid Epidemic: ‘These Are Essentially Heroin Pills,’ Expert Says
Stamford Advocate / Posted 7 days ago
United States were “pretty rare.” That changed, however, due to a “brilliant marketing campaign” by pharmaceutical company Purdue Pharma as it introduced its product Oxycontin to the market in 1996. “It was a multi-faceted campaign that led the... Read more
3 related stories
8d
Channel NewsAsia
Collegium Pharma's opioid painkiller wins US approvalXtampza ER, won a tentative approval in November, but full approval was conting
Collegium Pharma's opioid painkiller wins US approval
Channel NewsAsia / Posted 8 days ago
Xtampza ER, won a tentative approval in November, but full approval was contingent on the outcome of a lawsuit filed by Purdue Pharma against Collegium. Purdue Pharma, which has also developed abuse-deterrent versions of the commonly prescribed... Read more
13d
Bangor Daily News
How the maker of Oxycontin helped spark the opioid epidemicas “Killer.” The sources of the opioid epidemic are complex, but one powerful
How the maker of Oxycontin helped spark the opioid epidemic
Bangor Daily News / Posted 13 days ago
as “Killer.” The sources of the opioid epidemic are complex, but one powerful motivator has been the pursuit of profit. Purdue Pharma, which calls itself a “pioneer in developing medications for reducing pain, a principal cause of human... Read more
14d
CTV News
U.S. coalition slams Health Canada over opioid regulationsas OxyContin, and banning them all would cause pain and suffering for the patie
U.S. coalition slams Health Canada over opioid regulations
CTV News / Posted 14 days ago
as OxyContin, and banning them all would cause pain and suffering for the patients who needed them. OxyContin producer Purdue Pharma replaced the drug with a version called OxyNeo, which was supposed to be harder to crush and snort or... Read more
15d
Raw Story
Legal opioid drugs have proven far more dangerous than illegal onesas “Killer.” The sources of the opioid epidemic are complex, but one powerful
Legal opioid drugs have proven far more dangerous than illegal ones
Raw Story / Posted 15 days ago
as “Killer.” The sources of the opioid epidemic are complex, but one powerful motivator has been the pursuit of profit. Purdue Pharma, which calls itself a “pioneer in developing medications for reducing pain, a principal cause of human... Read more
16d
Business Wire
Global Laxatives Market to 2022 - Emerging Markets Present Lucrative Opportunity for GrowthMarket Analysis, By Geography 7 Company Profiles 7.1 Bayer AG 7.2 Boehringer
Global Laxatives Market to 2022 - Emerging Markets Present Lucrative Opportunity for Growth
Business Wire / Posted 16 days ago
Market Analysis, By Geography 7 Company Profiles 7.1 Bayer AG 7.2 Boehringer Ingelheim Pharmaceuticals, Inc. 7.3 GlaxoSmithKline Consumer Healthcare, L.P. 7.4 Procter & Gamble Company 7.5 Purdue Pharma 7.6 Sucampo Pharmaceu... Read more
20d
CIO
Millennials force CIOs to rethink tech, training processes– those between the ages of 18 and -- who aren’t shy about expressing their pre
Millennials force CIOs to rethink tech, training processes
CIO / Posted 20 days ago
– those between the ages of 18 and -- who aren’t shy about expressing their preference to learn on their own terms. Purdue Pharma CIO Larry Pickett says he is training up employees as he deploys cloud software and agile methodologies... Read more
21d
FOX News
The fed's new 'war on drugs': Obama proposes $1.1 billion to expand care for opioid addictsthose decades downplayed the risks of long-term opioid abuse and encouraged the
The fed's new 'war on drugs': Obama proposes $1.1 billion to expand care for opioid addicts
FOX News / Posted 21 days ago
those decades downplayed the risks of long-term opioid abuse and encouraged their use. In 2007, OxyContin producer Purdue Pharma paid $634.5 million in fines for harmful advertising of the drug. Data shows opioids are among the most... Read more
58 related stories
30d
Business Standard India
Lupin launches generic insomnia drug in USdeal earlier this month. It had announced the acquisition on July 23, 2015. G
Lupin launches generic insomnia drug in US
Business Standard India / Posted 30 days ago
deal earlier this month. It had announced the acquisition on July 23, 2015. GAVIS's product is the generic equivalent of Purdue Pharma LP's Intermezzo Sublingual tablets and is indicated for for the treatment of insomnia. According to the IMS... Read more
30d
The Economic Times
Lupin launches generic insomnia drug in USdeal earlier this month. It had announced the acquisition on July 23, 2015. G
Lupin launches generic insomnia drug in US
The Economic Times / Posted 30 days ago
deal earlier this month. It had announced the acquisition on July 23, 2015. GAVIS's product is the generic equivalent of Purdue Pharma LP's Intermezzo Sublingual tablets and is indicated for for the treatment of insomnia. As per the IMS sales... Read more
m
Orlando Sentinel
Obama calls for aggressive steps to curb opioid abuse epidemictwo Vietnam Wars of people dying." The CDC on March 15 published guidelines fo
Obama calls for aggressive steps to curb opioid abuse epidemic
Orlando Sentinel / Posted 1 months ago
two Vietnam Wars of people dying." The CDC on March 15 published guidelines for doctors who prescribe opioids, such as Purdue Pharma Inc.'s Oxycontin, to treat chronic pain, cautioning them against turning to the powerful and addictive pills... Read more
12 related stories
m
KERA North Texas
How A Painkiller Designed To Deter Abuse Helped Spark An HIV Outbreaksame old drug, ... and then that way they have a new drug that they can charge
How A Painkiller Designed To Deter Abuse Helped Spark An HIV Outbreak
KERA North Texas / Posted 1 months ago
same old drug, ... and then that way they have a new drug that they can charge a lot of money for." For example, in 2010, Purdue Pharma reformulated its popular opioid painkiller OxyContin to make the drug crush-resistant. The FDA later determined... Read more

People in this news